Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury

Ischemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astroglios...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tetsu Kimura, Yuta Horikoshi, Chika Kuriyagawa, Yukitoshi Niiyama
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Rho
Acceso en línea:https://doaj.org/article/825ffe2bb9ec48eb8412a7d27adc8b16
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:825ffe2bb9ec48eb8412a7d27adc8b16
record_format dspace
spelling oai:doaj.org-article:825ffe2bb9ec48eb8412a7d27adc8b162021-11-11T17:03:22ZRho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury10.3390/ijms2221115731422-00671661-6596https://doaj.org/article/825ffe2bb9ec48eb8412a7d27adc8b162021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11573https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Ischemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astrogliosis, and axon growth inhibition in IS and SCI. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), were previously considered to be non-functional. However, they have attracted much attention because they play an essential role in regulating gene expression in physiological and pathological conditions. There is growing evidence that ROCK inhibitors, such as fasudil and VX-210, can reduce injury in IS and SCI in animal models and clinical trials. Recently, it has been reported that miRNAs are decreased in IS and SCI, while lncRNAs are increased. Inhibiting the Rho/ROCK pathway with miRNAs alleviates apoptosis, neuroinflammation, oxidative stress, and axon growth inhibition in IS and SCI. Further studies are required to explore the significance of ncRNAs in IS and SCI and to establish new strategies for preventing and treating these devastating diseases.Tetsu KimuraYuta HorikoshiChika KuriyagawaYukitoshi NiiyamaMDPI AGarticlestrokespinal cord injuryRhoRho kinasenoncoding RNAapoptosisBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11573, p 11573 (2021)
institution DOAJ
collection DOAJ
language EN
topic stroke
spinal cord injury
Rho
Rho kinase
noncoding RNA
apoptosis
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle stroke
spinal cord injury
Rho
Rho kinase
noncoding RNA
apoptosis
Biology (General)
QH301-705.5
Chemistry
QD1-999
Tetsu Kimura
Yuta Horikoshi
Chika Kuriyagawa
Yukitoshi Niiyama
Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
description Ischemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astrogliosis, and axon growth inhibition in IS and SCI. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), were previously considered to be non-functional. However, they have attracted much attention because they play an essential role in regulating gene expression in physiological and pathological conditions. There is growing evidence that ROCK inhibitors, such as fasudil and VX-210, can reduce injury in IS and SCI in animal models and clinical trials. Recently, it has been reported that miRNAs are decreased in IS and SCI, while lncRNAs are increased. Inhibiting the Rho/ROCK pathway with miRNAs alleviates apoptosis, neuroinflammation, oxidative stress, and axon growth inhibition in IS and SCI. Further studies are required to explore the significance of ncRNAs in IS and SCI and to establish new strategies for preventing and treating these devastating diseases.
format article
author Tetsu Kimura
Yuta Horikoshi
Chika Kuriyagawa
Yukitoshi Niiyama
author_facet Tetsu Kimura
Yuta Horikoshi
Chika Kuriyagawa
Yukitoshi Niiyama
author_sort Tetsu Kimura
title Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_short Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_full Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_fullStr Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_full_unstemmed Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
title_sort rho/rock pathway and noncoding rnas: implications in ischemic stroke and spinal cord injury
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/825ffe2bb9ec48eb8412a7d27adc8b16
work_keys_str_mv AT tetsukimura rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury
AT yutahorikoshi rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury
AT chikakuriyagawa rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury
AT yukitoshiniiyama rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury
_version_ 1718432188017410048